Mr. Todd Shapiro reports

RED LIGHT HOLLAND ANNOUNCES DR. ROBIN CARHART-HARRIS AS SCIENTIFIC ADVISOR

Red Light Holland Corp. has appointed Dr. Robin Carhart-Harris, a leading authority in psychedelic research, as an independent scientific adviser.

Dr. Carhart-Harris will provide strategic guidance on psilocybin research developments and assist with potential academic and regulatory collaborations. The advisory role will also include regular science-focused discussions to help advance the company's research initiatives and educational outreach efforts with the aim of increasing safety and responsible access, if and when regulations permit.

"Dr. Robin Carhart-Harris is a true pioneer in psychedelic research, and his groundbreaking work has helped shape the global conversation around mental health innovation," said Todd Shapiro, chief executive officer and director of Red Light Holland. "Having him join as a scientific adviser is not only an honour, it reinforces our dedication to advancing safe, effective and evidence-based psychedelic solutions through world-class scientific leadership."

The appointment of Dr. Carhart-Harris represents another significant step in Red Light Holland's expanding scientific and market entry strategy, which includes:

• A successful partnership with Dr. David Nutt and Drug Science, analyzing consensual data from the company's microdosing app in the Netherlands;
• Development of accurately dosed natural microdosing capsules with CCREST Labs in Montreal, Canada, via four separate Health Canada-approved psilocybin import permits of the company's naturally occurring psilocybin;
• Collaborating with Food and Drug Administration-compliant and Drug Enforcement Administration-registered Irvine Labs in California, which has recently received a United States Controlled Substances Import Permit for the company's naturally occurring psilocybin and will be working toward increasing the shelf life of the microdosing capsules;
• Distribution agreement with Allu Therapeutics, a specialized entity spun out from NUBU Pharmaceuticals in June, 2024, focused solely on distribution and sales of psychedelic products in Australia and New Zealand. Notably, New Zealand has recently allowed for a first prescriber of psilocybin outside of a research setting;
• An upcoming collaboration with Arizona State University to support groundbreaking psychedelic genome project (PGP) research study.

As global markets continue to open up for therapeutic psychedelics, including some very recent positive news in the United States, New Zealand and Czech Republic, Red Light Holland continues to strategically position itself to leverage both their valuable real-world data collected from its operations and insights gained through strategic partnerships to maintain its responsible use policy and support evidence-based approaches to psychedelic medicine.

About Red Light Holland Corp.

Red Light Holland is an Ontario-based corporation engaged in the production, growth, and sale of functional mushrooms and mushroom home grow kits in North America and Europe, and a premium brand of psilocybin truffles to the legal, recreational market within the Netherlands, in compliance with all applicable laws.

We seek Safe Harbor.